Email
IAC Express #1,591 - Upcoming ACIP meeting on COVID-19 boosters. IAC updates Ask the Experts - what's new for the 2021–22 flu season, and more.
| From | Immunization Action Coalition <[email protected]> |
| Subject | IAC Express #1,591 - Upcoming ACIP meeting on COVID-19 boosters. IAC updates Ask the Experts - what's new for the 2021–22 flu season, and more. |
| Date | September 22, 2021 10:01 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,591: September 22, 2021
Top Stories
* September 22–23: Watch the virtual ACIP meeting on COVID-19 vaccine booster policy; no registration required
* CDC updates “Vaccines & Immunizations: COVID-19 Vaccines” web page, including two new sections
* IAC updates its "Ask the Experts: Influenza" web page to answer questions about what's new from ACIP for the 2021–22 influenza season
* "Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations among Adults without Immunocompromising Conditions—United States, March–August 2021" published in MMWR Early Release
* IAC posts Russian translations of 14 new Vaccine Information Statements (VISs) issued by CDC on August 6
* IAC Spotlight: Check out IAC’s companion websites
* Journalists interview IAC experts
* Vaccines in the news
Vaccine Information Statements
* IAC posts new translations of current VISs in Chinese, Dari, Pashto, Spanish, Turkish, and Vietnamese
Featured Resources
* Spread the word, not the virus! IAC offers FREE “I Got My COVID-19 Vaccine” buttons and stickers to those promoting vaccination in hesitant communities. Available in English and Spanish.
* IAC's red "FLU VACCINE" buttons and stickers are a bright idea. Order today!
* Vaccinated against COVID-19? Encourage friends to follow your lead by adding IAC’s “I Got My COVID-19 Vaccine” Facebook profile photo frame.
* Great gift idea! IAC's elegantly designed "Vaccines Save Lives" black enamel pins make wonderful holiday gifts or workplace recognitions.
Notable Publications
* “New COVID-19 Cases and Hospitalizations among Adults, by Vaccination Status—New York, May 3–July 25, 2021” published in MMWR
* “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months” published in NEJM
* MMWR Recap: COVID-19 vaccine effectiveness studies
Global News
* September 28 is World Rabies Day
Upcoming Events
* Virtual: Watch the ACIP meeting on tick-borne encephalitis, zoster, and pneumococcal vaccination on September 29; no registration required
* Virtual: View the panel discussions “Partners in Vaccination: A Collaboration between the AAP, AIM, and NACCHO” on September 29 and October 13
* Virtual: Unity Consortium offers webinar “Working Together to Protect Our Adolescents in School Environments from Vaccine-Preventable Diseases” moderated by Chelsea Clinton on September 30
* Virtual: Nevada Immunization Learning Exchange offers webinar titled “COVID-19 Vaccine and Delta Variant: Facts vs. Misinformation” on September 30
------------------------------------------------------------
Top Stories
------------------------------------------------------------
September 22–23: Watch the virtual ACIP meeting on COVID-19 vaccine booster policy; no registration required
CDC will convene its Advisory Committee on Immunization Practices (ACIP) ([link removed]) on September 22 from 10:00 a.m.–5:00 p.m. (ET) and September 23 from 11:00 a.m.–2:00 p.m. (ET). The committee will discuss COVID-19 booster dose policy.
[link removed]
No registration is required to watch webcasts of live ACIP meetings or listen via telephone.
Related Link
* ACIP gateway page ([link removed]) for content from previous meetings, as well as information about future meetings
------------------------------------------------------------
CDC updates its “Vaccines & Immunizations: COVID-19 Vaccines” web page, including two new sections
CDC updated its Vaccines & Immunizations: COVID-19 Vaccines ([link removed]) web page to reflect recent changes including:
* A new section on Vaccinating People Receiving Medical Care Unrelated to COVID-19 ([link removed])
* A new section on Vaccinating People Undergoing SARS-CoV-2 Screening ([link removed])
* Updated information in the section on COVID-19 Vaccination and SARS-CoV-2 Infection ([link removed])
* Updated information in the section on Vaccinating People with a Known COVID-19 Exposure or during COVID-19 Outbreaks ([link removed])
View CDC's Vaccines & Immunizations: COVID-19 Vaccines ([link removed]) web page.
------------------------------------------------------------
IAC updates its "Ask the Experts: Influenza" web page to answer questions about what's new from ACIP for the 2021–22 influenza season
IAC has updated its Ask the Experts: Influenza ([link removed]) web page to reflect important Q&As about updates to Advisory Committee on Immunization Practices (ACIP) recommendations for influenza vaccination for the 2021–22 flu season.
The Ask the Experts: Influenza ([link removed]) web page is updated as guidance and vaccine authorizations change.
[link removed]
IAC's Ask the Experts ([link removed]) gateway page leads you to 29 distinct web pages on a variety of topics with more than 1,000 common or challenging questions and answers (Q&As) about vaccines and their administration. IAC's team of experts includes Kelly L. Moore, MD, MPH and Carolyn B. Bridges, MD, FACP.
Related Links
* IAC: Ask the Experts: Influenza ([link removed]) web page
* IAC: Ask the Experts ([link removed]) gateway page to access more than 1,000 questions answered by IAC experts
* IAC: Vaccines: Influenza ([link removed]) gateway page
* IAC: Handouts: Influenza ([link removed]) gateway page
* CDC: Vaccine Recommendations and Guidelines of the ACIP: Influenza ([link removed]) gateway page
------------------------------------------------------------
"Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations among Adults without Immunocompromising Conditions—United States, March–August 2021" published in MMWR Early Release
CDC published Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations among Adults without Immunocompromising Conditions—United States, March–August 2021 ([link removed]) ([link removed]) in the September 17 MMWR Early Release. A portion of the summary appears below.
Among U.S. adults without immunocompromising conditions, vaccine effectiveness against COVID-19 hospitalization during March 11–August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%)....
Although these real-world data suggest some variation in levels of protection by vaccine, all FDA-approved or authorized COVID-19 vaccines provide substantial protection against COVID-19 hospitalization.
Access the MMWR Early Release article in HTML ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's gateway page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
IAC posts Russian translations of 14 new Vaccine Information Statements (VISs) issued by CDC on August 6
IAC has posted Russian translations ([link removed]) for 14 current Vaccine Information Statements ([link removed]) (VISs) issued by CDC August 6, 2021. The translations are available in PDF format.
* DTaP (Diphtheria, Tetanus, Pertussis) PDF ([link removed] ) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) PDF ([link removed]) (view in English ([link removed]) )
* HPV (Human Papillomavirus) PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated PDF ([link removed]) (view in English ([link removed]) )
* Influenza, live intranasal PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B PDF ([link removed]) (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) PDF ([link removed]) (view in English ([link removed]) )
* MMRV (Measles, Mumps, Rubella, and Varicella) PDF ([link removed]) (view in English ([link removed]) )
* Pneumococcal Conjugate (PCV13) PDF ([link removed]) (view in English ([link removed]) )
* Polio PDF ([link removed]) (view in English ([link removed]) )
* Td (Tetanus, Diphtheria) PDF ([link removed]) (view in English ([link removed]) )
* Tdap (Tetanus, Diphtheria, Pertussis) PDF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) PDF ([link removed]) (view in English ([link removed]) )
[link removed]
CDC encourages providers to begin using these VISs immediately; however, existing supplies of the previous editions may be used until they are depleted.
IAC will post translations of current VISs into additional languages in the coming weeks at ;Immunize.org/vis ([link removed]) . Translations of previous VIS versions may be used until new translations become available. CDC states that the corresponding current English-language VIS must also be supplied when providing an out-of-date translation.
Related Links
* IAC: Vaccine Information Statements ([link removed]) gateway page for VISs in 47 languages ([link removed])
* IAC: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
IAC SPOTLIGHT: CHECK OUT IAC’S COMPANION WEBSITES
In this week's IAC Spotlight, we summarize Immunize.org companion websites.
Information about the National Network of Immunization Coalitions, a project of IAC, can be found at www.immunizationcoalitions.org ([link removed]) . This website compiles information on more than 100 immunization coalitions throughout the United States. It’s a place for coalitions to find out about each other—their location, leaders, and work—as well as to learn about topics of shared interest.
The National Adult and Influenza Immunization Summit (NAIIS) website at www.izsummitpartners.org is dedicated to addressing adult and influenza immunization issues and improving coverage. The NAIIS has over 700 members, representing more than 130 public and private organizations. Leadership of the NAIIS is provided through the members of the Summit Organizing Committee (SOC), including IAC, CDC, and HHS representatives.
Vaccine Information You Need at www.vaccineinformation.org ([link removed]) was launched by IAC in partnership with CDC to help inform the public. This website provides hundreds of valuable resources, including personal testimonies of suffering and loss due to vaccine-preventable diseases, vaccine-related videos and public service announcements, and educational materials from trusted organizations.
MenACWY: You’re Not Done If You Give Just One at www.give2menacwy.org supports a national campaign to improve protection from disease caused by meningococcal serogroups A, C, W, and Y. It offers information for families and resources for providers to boost on-time delivery of both doses of the MenACWY vaccine series.
65+ Flu Defense at www.influenza-defense.orgis a public health service produced by IAC and Seqirus. The website offers tools and resources to help protect patients 65 and older, all of whom are at greater risk of influenza complications.
Related Link
* IAC: IAC Immunization Partners ([link removed]) gateway page
------------------------------------------------------------
Journalists interview IAC experts
Journalists seek out IAC experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is a selection of our recent citations.
* Scientific American: An mRNA Pioneer Discusses How Her Work Led to the COVID Vaccines ([link removed]) (9/15/21)
* Washington Post:The U.S. Was a Global Leader in Vaccinations. Now It’s Falling Behind. ([link removed]) (9/15/21)
* Washington Times: 'Twindemic' Possible as Flu Season Approaches, Health Experts Warn ([link removed]) (9/14/21)
Related Link
* IAC in the News ([link removed]) gateway page
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* STAT News: FDA Advisory Panel Recommends Booster Doses of COVID-19 Vaccine Only for Older and High-Risk Americans ([link removed]) (9/17/21)
* The Conversation: What’s the Law on Vaccine Exemptions? A Religious Liberty Expert Explains ([link removed]) (9/15/21)
* Business Mirror: Life-Course Immunization Is Key to Promoting Healthy Ageing ([link removed]) (9/15/21)
* Washington Post: Fauci Says He Supports Vaccine Mandates for Air Travel. Will It Actually Fly? ([link removed]) (9/13/21)
* NBC: 'Hybrid Immunity': ([link removed]) Why People Who Had COVID Should Still Get Vaccinated ([link removed]) (9/13/21)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
IAC POSTS NEW TRANSLATIONS OF CURRENT VISS IN CHINESE, DARI, PASHTO, SPANISH, TURKISH, AND VIETNAMESE
IAC has posted new and updated translations of Vaccine Information Statements ([link removed]) (VISs) that were released by CDC on August 6, 2021, in Chinese, Dari, Pashto, Spanish, Turkish, and Vietnamese. All translations are available in PDF and print-ready format.
VIS translations in Simplified Chinese and Traditional Chinese ([link removed]) :
* DTaP (Diphtheria, Tetanus, Pertussis) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* HPV (Human Papillomavirus) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Influenza, inactivated or recombinant in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Influenza, live intranasal in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Meningococcal ACWY in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Meningococcal B in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* MMRV (Measles, Mumps, Rubella, and Varicella) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Pneumococcal Conjugate (PCV13) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Polio in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Td (Tetanus, Diphtheria) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Tdap (Tetanus, Diphtheria, Pertussis) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Varicella (Chickenpox) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
Simplified Chinese is preferred in China, Singapore, and Malaysia. Traditional Chinese is preferred in Hong Kong, Macau, and Taiwan.
VIS translations in Dari ([link removed]) :
* MMR (Measles, Mumps, and Rubella) PDF ([link removed]) (view in English ([link removed]) )
* Polio PDF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) PDF ([link removed]) (view in English ([link removed]) )
Dari is spoken by some people in Afghanistan and Pakistan. These VIS translations were provided to IAC by the Multilingual Services of CDC.
VIS translations in Pashto ([link removed]) :
* Hepatitis A PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated PDF ([link removed]) (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) PDF ([link removed]) (view in English ([link removed]) )
* Polio PDF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) PDF ([link removed]) (view in English ([link removed]) )
Pashto is spoken by some people in Afghanistan, Iran, and Pakistan. These VIS translations were provided to IAC by the Multilingual Services of CDC. All files are dated 8/6/2021 except for Hepatitis A which is dated 7/28/2020.
VIS translation in Spanish ([link removed]) :
The translations are available in PDF and Rich Text Format (RTF). RTF is used by electronic health record systems that cannot accept PDFs.
* DTaP (Diphtheria, Tetanus, Pertussis) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* HPV (Human Papillomavirus) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated or recombinant in PDF ([link removed]) and RTF ([link removed]) formats (view in English ([link removed]) )
* Influenza, live intranasal in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Meningococcal B in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* MMRV (Measles, Mumps, Rubella, and Varicella) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Pneumococcal Conjugate (PCV13) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Polio in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Td (Tetanus, Diphtheria) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Tdap (Tetanus, Diphtheria, Pertussis) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
VIS translation in Turkish ([link removed]) :
* Influenza, live intranasal PDF ([link removed]) (view in English ([link removed]) )
This translation is generously donated by Betül Polatdemir, MD, from Ankara, Turkey, and Sibel Bostancıoğlu, MD, from the Occupational and Environmental Diseases Hospital of Ankara.
VIS translations in Vietnamese ([link removed]) :
* DTaP (Diphtheria, Tetanus, Pertussis) PDF ([link removed]) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) PDF ([link removed]) (view in English ([link removed]) )
* HPV (Human Papillomavirus) PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated PDF ([link removed]) (view in English ([link removed]) )
* Influenza, live intranasal PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B PDF ([link removed]) (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) PDF ([link removed]) (view in English ([link removed]) )
* MMRV (Measles, Mumps, Rubella, and Varicella) PDF ([link removed]) (view in English ([link removed]) )
* Pneumococcal Conjugate (PCV13) PDF ([link removed]) (view in English ([link removed]) )
* Polio PDF ([link removed]) (view in English ([link removed]) )
* Td (Tetanus, Diphtheria) PDF ([link removed]) (view in English ([link removed]) )
* Tdap (Tetanus, Diphtheria, Pertussis) PDF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) PDF ([link removed]) (view in English ([link removed]) )
IAC will post translations of current VISs into additional languages in coming weeks at Immunize.org/vis ([link removed]) .
Translations of previous VIS versions may be used until translations of current VISs become available. CDC states that the corresponding current English-language VIS must also be supplied when providing a translation of a previous version.
Related Links
* IAC: Vaccine Information Statements ([link removed]) gateway page for VISs in 47 languages ([link removed])
* IAC: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Spread the word, not the virus! IAC offers FREE “I Got My COVID-19 Vaccine” buttons and stickers to those promoting vaccination in hesitant communities. Available in English and Spanish.
Any group or person promoting COVID-19 vaccination can order IAC’s FREE “I Got My COVID-19 Vaccine” buttons and stickers ([link removed]) , provided with support from CDC. Available in English and Spanish, the buttons and stickers look great on lab coats, uniforms, jackets, lanyards, ID badges, or backpacks to show confidence in COVID-19 vaccination. Access this order form ([link removed]) to request the FREE buttons and stickers for your outreach efforts while supplies last.
[link removed] [link removed]
Related Links
* IAC: FREE "I Got My COVID-19 Vaccine" buttons and stickers order form ([link removed])
* Shop IAC ([link removed]) gateway page: All the buttons, stickers, laminated schedules, record cards, and other products offered by IAC
------------------------------------------------------------
IAC'S RED "FLU VACCINE" BUTTONS AND STICKERS ARE A BRIGHT IDEA. ORDER TODAY!
Remember to order your IAC “FLU VACCINE” buttons and stickers ([link removed]) They are ready to ship! Their bright red color highlights your important message about the need for influenza vaccination. And the cost is reasonable.
[link removed]
“FLU VACCINE” BUTTONS
The button measures 1.25" across and carries a bold message! Pin on lab coats, uniforms, other clothing, tote bags, or backpacks to show support for flu vaccine.
Buttons are delivered in bags of 10 buttons per bag.
Click here for pricing and ordering information for "FLU VACCINE" buttons ([link removed]) .
“FLU VACCINE” STICKERS
Measuring 1.5" across, these stickers adhere well to clothing and have an easy-peel-off backing.
Stickers are delivered to you cut individually (not on rolls)—available in bundles of 100.
Click here for pricing and ordering information for “FLU VACCINE” stickers. ([link removed])
Visit Shop IAC for additional items ([link removed]) , including "Vaccines Save Lives" enamel pins, patient record cards, and a vaccine administration training video.
------------------------------------------------------------
Vaccinated against COVID-19? Encourage friends to follow your lead by adding IAC’s “I Got My COVID-19 Vaccine” Facebook profile photo frame.
Share your excitement about COVID-19 vaccination and inspire your friends! After you are vaccinated against COVID-19, add IAC's new "I Got My COVID-19 Vaccine" Facebook photo frame to liven up your profile picture!
You can obtain the frame in three ways:
* Click your profile picture, select “update picture,” and then select “add a frame.” Search for #igotmycovid19vaccine and select it.
* Accept the frame in English by clicking this link: www.facebook.com/profilepicframes/? selected_overlay_id=2361854253958052 ([link removed])
* Accept the frame in Spanish by clicking this link: www.facebook.com/profilepicframes/?selected_overlay_id=517990259207530
------------------------------------------------------------
GREAT GIFT IDEA! IAC'S ELEGANTLY DESIGNED "VACCINES SAVE LIVES" BLACK ENAMEL PINS MAKE WONDERFUL HOLIDAY GIFTS OR WORKPLACE RECOGNITIONS.
IAC’s elegantly designed “Vaccines Save Lives” pins ([link removed]) are meaningful gifts for people who care about vaccination. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75".
[link removed]
The pin is a stick-through-post variety with the back end covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided.
Wear these pins on clothing, ([link removed]) uniforms, and white coats to show that you value vaccines!
([link removed])
Click here for "Vaccines Save Lives" pin pricing and ordering information. ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“New COVID-19 Cases and Hospitalizations among Adults, by Vaccination Status—New York, May 3–July 25, 2021” published in MMWR
CDC published New COVID-19 Cases and Hospitalizations among Adults, by Vaccination Status—New York, May 3–July 25, 2021 ([link removed]) in the September 17 MMWR. A portion of the summary appears below.
Real-world studies of population-level vaccine effectiveness against laboratory-confirmed SARS-CoV-2 infection and COVID-19 hospitalizations are limited in the United States....
During May 3–July 25, 2021, the overall age-adjusted vaccine effectiveness against hospitalization in New York was relatively stable 89.5%–95.1%. The overall age-adjusted vaccine effectiveness against infection for all New York adults declined from 91.8% to 75.0%....
These findings support the implementation of multicomponent approach to controlling the pandemic, centered on vaccination, as well as other prevention strategies such as masking and physical distancing.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's gateway page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
“Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months” published in NEJM
In the September 15 issue, NEJM published Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months ([link removed]) . A portion of the abstract appears below.
[Pfizer-BioNTech’s] BNT162b2 is highly efficacious against coronavirus disease 2019 (Covid-19) and is currently approved, conditionally approved, or authorized for emergency use worldwide. At the time of initial authorization, data beyond 2 months after vaccination were unavailable....
In an ongoing, placebo-controlled, observer-blinded, multinational, pivotal efficacy trial, we randomly assigned 44,165 participants 16 years of age or older and 2264 participants 12 to 15 years of age to receive two 30-μg doses, at 21 days apart, of BNT162b2 or placebo. The trial end points were vaccine efficacy against laboratory-confirmed Covid-19 and safety, which were both evaluated through 6 months after vaccination....
BNT162b2 continued to be safe and have an acceptable adverse-event profile. Few participants had adverse events leading to withdrawal from the trial. Vaccine efficacy against Covid-19 was 91.3%…through 6 months of follow-up among the participants without evidence of previous SARS-CoV-2 infection who could be evaluated. There was a gradual decline in vaccine efficacy. Vaccine efficacy of 86 to 100% was seen across countries and in populations with diverse ages, sexes, race or ethnic groups, and risk factors for Covid-19 among participants without evidence of previous infection with SARS-CoV-2. Vaccine efficacy against severe disease was 96.7%…In South Africa, where the SARS-CoV-2 variant of concern B.1.351 (or beta) was predominant, a vaccine efficacy of 100%…was observed....
Through 6 months of follow-up and despite a gradual decline in vaccine efficacy, BNT162b2 had a favorable safety profile and was highly efficacious in preventing Covid-19.
------------------------------------------------------------
MMWR Recap: COVID-19 vaccine effectiveness studies
CDC recently published several articles first distributed as MMWR Early Releases:
* Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status––13 U.S. Jurisdictions, April 4–July 17, 2021 (MMWR, September 17, HTML ([link removed]) or PDF ([link removed]) )
* Interim Estimates of COVID-19 Vaccine Effectiveness against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations among Adults during SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance––Nine States, June–August 2021 (MMWR, September 17, HTML ([link removed]) or PDF ([link removed]) )
* Effectiveness of COVID-19 mRNA Vaccines against COVID-19–Associated Hospitalization—Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021 (MMWR, September 17, HTML ([link removed](Delta)%20variant.) or PDF ([link removed]) )
Related Link
* MMWR ([link removed]) gateway page provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
Global News
------------------------------------------------------------
SEPTEMBER 28 IS WORLD RABIES DAY
September 28 is World Rabies Day ([link removed]) , a global health observance started in 2007 to raise awareness about rabies and bring together partners to enhance prevention and control efforts worldwide. While rabies ([link removed]) is a 100% preventable disease, more than 59,000 people die from the disease around the world each year. World Rabies Day is an opportunity to reflect on our efforts to control this deadly disease and remind ourselves that the fight is not yet over.
September 28 was chosen because it is the anniversary of the death of Louis Pasteur, the French chemist and microbiologist who developed the first rabies vaccine. Today, safe and effective animal and human vaccines are important tools to eliminate human deaths from rabies but awareness is the key driver for effective rabies prevention.
[link removed]
Access the World Rabies Day ([link removed]) website for more information.
Related Links
* CDC: World Rabies Day ([link removed]) web page
* CDC: Rabies ([link removed]) web page
* WHO: September 28 is World Rabies Day ([link removed]) web page
* IAC: ACIP Recommendations: Rabies ([link removed]) web page
* IAC: Vaccines: Rabies ([link removed]) gateway page
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
VIRTUAL: WATCH THE ACIP MEETING ON TICK-BORNE ENCEPHALITIS, ZOSTER, AND PNEUMOCOCCAL VACCINATION ON SEPTEMBER 29; NO REGISTRATION REQUIRED
CDC will convene its Advisory Committee on Immunization Practices (ACIP) ([link removed]) on September 29, starting at 10:00 a.m. (ET). The committee will discuss tick-borne encephalitis, zoster, and pneumococcal vaccination.
No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described at the website.
View the agenda ([link removed]) .
Related Link
* ACIP gateway page ([link removed]) for content from previous meetings, as well as information about future meetings
------------------------------------------------------------
VIRTUAL: VIEW THE PANEL DISCUSSIONS “PARTNERS IN VACCINATION: A COLLABORATION BETWEEN THE AAP, AIM, AND NACCHO” ON SEPTEMBER 29 AND OCTOBER 13
The American Academy of Pediatrics (AAP), the Association of Immunization Managers (AIM), and the National Association of County and City Health Officials (NACCHO) will host "Partners in Vaccination: A Collaboration Between the AAP, AIM, and NACCHO" panel discussions from 11:30 a.m.–1:00 p.m. (CT) on both September 29 ([link removed]) and October 13
([link removed]) . These discussions will lead to a shared understanding of the role each plays in routine childhood immunization and pathways to collaboration at the local and/or state levels.
A panelist from each organization will provide a brief overview of their organization, describe the current environment for providing routine childhood immunizations, and share an illustrative example of a successful collaboration among them. Participants will come away with ideas on how to leverage their organization’s role and strengths.
Register for the September 29 session. ([link removed])
Register for the October 13 session. ([link removed])
------------------------------------------------------------
VIRTUAL: UNITY CONSORTIUM OFFERS WEBINAR “WORKING TOGETHER TO PROTECT OUR ADOLESCENTS IN SCHOOL ENVIRONMENTS FROM VACCINE-PREVENTABLE DISEASES” MODERATED BY CHELSEA CLINTON ON SEPTEMBER 30
Unity Consortium will offer Working Together to Protect Our Adolescents in School Environments from Vaccine-Preventable Diseases ([link removed]) panel discussion moderated by Chelsea Clinton on September 30 from 12:00–1:00 p.m. (ET).
The panel includes distinguished leaders from
* American Association of School Administrators (AASA)
* National School Boards Association (NSBA)
* National Association of County, and City Health Officials (NACCHO)
They will discuss promising practices that schools have adopted to help keep students and school employees safe and healthy.
Register for the event ([link removed]) .
If you can't attend, register so you will be sent the recording.
------------------------------------------------------------
Virtual: Nevada Immunization Learning Exchange offers webinar titled “COVID-19 Vaccine and Delta Variant: Facts vs. Misinformation” on September 30
Nevada Immunization Learning Exchange (NILE) will offer a webinar titled COVID-19 Vaccine and Delta Variant: Facts vs. Misinformation ([link removed]) on September 30 at 11:30 a.m. (PT). During this program, Dr. Katrine Wallace, PhD, MS, will describe recently published research on COVID-19 vaccines’ effectiveness against the Delta variant and some common vaccine misinformation on social media. The learning objectives include:
* Learn current COVID-19 vaccine effectiveness estimates against the Delta variant
* Learn methodological issues associated with determining vaccine effectiveness against infection
* Discern facts from misleading information being circulated on social media and elsewhere
Register for the webinar ([link removed]) .
[link removed]
IAC Express
IAC Express Home ([link removed])
2021 Issues ([link removed])
2020 Issues ([link removed])
2019 Issues ([link removed])
2018 ([link removed]) – (#IACX4) 1997 Issues ([link removed])
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
------------------------------------------------------------
[link removed]
[link removed]
------------------------------------------------------------
Follow Us
[link removed]
[link removed]
------------------------------------------------------------
[link removed]
Read Dr. Wexler's column for the Vaccine Education Center's monthly newsletter, Vaccine Update
------------------------------------------------------------
Vaccinating Adults:
A Step-by-Step Guide
[link removed]
New! IAC's 142-page book available for free download ([link removed]) .
------------------------------------------------------------
Calendar of Events
[link removed]
Conferences, meetings, and training opportunities
------------------------------------------------------------
Patient Record Cards
[link removed]
Record cards for patients --child & teen ([link removed]) , adult ([link removed]) , and lifetime ([link removed]) -- are printed on durable paper and sized to fit in a wallet when folded
------------------------------------------------------------
DVD: Immunization Techniques
[link removed]
Every practice should have this award winning, "how-to" training video
------------------------------------------------------------
Protect Newborns Guidebook
[link removed]
Comprehensive guide Hepatitis B: What Hospitals Need to Do to Protect Newborns ([link removed])
------------------------------------------------------------
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH (mailto:[email protected])
Managing Editor
John Grabenstein, RPh, PhD (mailto:[email protected])
Associate Editor
Sharon Humiston, MD, MPH (mailto:[email protected])
Writer/Publication Coordinator
Taryn Chapman, MS (mailto:[email protected])
Courtnay Londo, MA (mailto:[email protected])
Style and Copy Editor
Marian Deegan, JD (mailto:[email protected])
Web Edition Manager
Sheila M. Franey, MA
Contributing Writer
Laurel H. Wood, MPA (mailto:[email protected])
Technical Reviewer
Robin VanOss (mailto:[email protected])
About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue ([link removed]) .
IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC.
IAC Express Disclaimer ([link removed])
ISSN: 1526-1786
Our mailing address:
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
[link removed]
Issue 1,591: September 22, 2021
Top Stories
* September 22–23: Watch the virtual ACIP meeting on COVID-19 vaccine booster policy; no registration required
* CDC updates “Vaccines & Immunizations: COVID-19 Vaccines” web page, including two new sections
* IAC updates its "Ask the Experts: Influenza" web page to answer questions about what's new from ACIP for the 2021–22 influenza season
* "Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations among Adults without Immunocompromising Conditions—United States, March–August 2021" published in MMWR Early Release
* IAC posts Russian translations of 14 new Vaccine Information Statements (VISs) issued by CDC on August 6
* IAC Spotlight: Check out IAC’s companion websites
* Journalists interview IAC experts
* Vaccines in the news
Vaccine Information Statements
* IAC posts new translations of current VISs in Chinese, Dari, Pashto, Spanish, Turkish, and Vietnamese
Featured Resources
* Spread the word, not the virus! IAC offers FREE “I Got My COVID-19 Vaccine” buttons and stickers to those promoting vaccination in hesitant communities. Available in English and Spanish.
* IAC's red "FLU VACCINE" buttons and stickers are a bright idea. Order today!
* Vaccinated against COVID-19? Encourage friends to follow your lead by adding IAC’s “I Got My COVID-19 Vaccine” Facebook profile photo frame.
* Great gift idea! IAC's elegantly designed "Vaccines Save Lives" black enamel pins make wonderful holiday gifts or workplace recognitions.
Notable Publications
* “New COVID-19 Cases and Hospitalizations among Adults, by Vaccination Status—New York, May 3–July 25, 2021” published in MMWR
* “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months” published in NEJM
* MMWR Recap: COVID-19 vaccine effectiveness studies
Global News
* September 28 is World Rabies Day
Upcoming Events
* Virtual: Watch the ACIP meeting on tick-borne encephalitis, zoster, and pneumococcal vaccination on September 29; no registration required
* Virtual: View the panel discussions “Partners in Vaccination: A Collaboration between the AAP, AIM, and NACCHO” on September 29 and October 13
* Virtual: Unity Consortium offers webinar “Working Together to Protect Our Adolescents in School Environments from Vaccine-Preventable Diseases” moderated by Chelsea Clinton on September 30
* Virtual: Nevada Immunization Learning Exchange offers webinar titled “COVID-19 Vaccine and Delta Variant: Facts vs. Misinformation” on September 30
------------------------------------------------------------
Top Stories
------------------------------------------------------------
September 22–23: Watch the virtual ACIP meeting on COVID-19 vaccine booster policy; no registration required
CDC will convene its Advisory Committee on Immunization Practices (ACIP) ([link removed]) on September 22 from 10:00 a.m.–5:00 p.m. (ET) and September 23 from 11:00 a.m.–2:00 p.m. (ET). The committee will discuss COVID-19 booster dose policy.
[link removed]
No registration is required to watch webcasts of live ACIP meetings or listen via telephone.
Related Link
* ACIP gateway page ([link removed]) for content from previous meetings, as well as information about future meetings
------------------------------------------------------------
CDC updates its “Vaccines & Immunizations: COVID-19 Vaccines” web page, including two new sections
CDC updated its Vaccines & Immunizations: COVID-19 Vaccines ([link removed]) web page to reflect recent changes including:
* A new section on Vaccinating People Receiving Medical Care Unrelated to COVID-19 ([link removed])
* A new section on Vaccinating People Undergoing SARS-CoV-2 Screening ([link removed])
* Updated information in the section on COVID-19 Vaccination and SARS-CoV-2 Infection ([link removed])
* Updated information in the section on Vaccinating People with a Known COVID-19 Exposure or during COVID-19 Outbreaks ([link removed])
View CDC's Vaccines & Immunizations: COVID-19 Vaccines ([link removed]) web page.
------------------------------------------------------------
IAC updates its "Ask the Experts: Influenza" web page to answer questions about what's new from ACIP for the 2021–22 influenza season
IAC has updated its Ask the Experts: Influenza ([link removed]) web page to reflect important Q&As about updates to Advisory Committee on Immunization Practices (ACIP) recommendations for influenza vaccination for the 2021–22 flu season.
The Ask the Experts: Influenza ([link removed]) web page is updated as guidance and vaccine authorizations change.
[link removed]
IAC's Ask the Experts ([link removed]) gateway page leads you to 29 distinct web pages on a variety of topics with more than 1,000 common or challenging questions and answers (Q&As) about vaccines and their administration. IAC's team of experts includes Kelly L. Moore, MD, MPH and Carolyn B. Bridges, MD, FACP.
Related Links
* IAC: Ask the Experts: Influenza ([link removed]) web page
* IAC: Ask the Experts ([link removed]) gateway page to access more than 1,000 questions answered by IAC experts
* IAC: Vaccines: Influenza ([link removed]) gateway page
* IAC: Handouts: Influenza ([link removed]) gateway page
* CDC: Vaccine Recommendations and Guidelines of the ACIP: Influenza ([link removed]) gateway page
------------------------------------------------------------
"Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations among Adults without Immunocompromising Conditions—United States, March–August 2021" published in MMWR Early Release
CDC published Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations among Adults without Immunocompromising Conditions—United States, March–August 2021 ([link removed]) ([link removed]) in the September 17 MMWR Early Release. A portion of the summary appears below.
Among U.S. adults without immunocompromising conditions, vaccine effectiveness against COVID-19 hospitalization during March 11–August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%)....
Although these real-world data suggest some variation in levels of protection by vaccine, all FDA-approved or authorized COVID-19 vaccines provide substantial protection against COVID-19 hospitalization.
Access the MMWR Early Release article in HTML ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's gateway page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
IAC posts Russian translations of 14 new Vaccine Information Statements (VISs) issued by CDC on August 6
IAC has posted Russian translations ([link removed]) for 14 current Vaccine Information Statements ([link removed]) (VISs) issued by CDC August 6, 2021. The translations are available in PDF format.
* DTaP (Diphtheria, Tetanus, Pertussis) PDF ([link removed] ) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) PDF ([link removed]) (view in English ([link removed]) )
* HPV (Human Papillomavirus) PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated PDF ([link removed]) (view in English ([link removed]) )
* Influenza, live intranasal PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B PDF ([link removed]) (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) PDF ([link removed]) (view in English ([link removed]) )
* MMRV (Measles, Mumps, Rubella, and Varicella) PDF ([link removed]) (view in English ([link removed]) )
* Pneumococcal Conjugate (PCV13) PDF ([link removed]) (view in English ([link removed]) )
* Polio PDF ([link removed]) (view in English ([link removed]) )
* Td (Tetanus, Diphtheria) PDF ([link removed]) (view in English ([link removed]) )
* Tdap (Tetanus, Diphtheria, Pertussis) PDF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) PDF ([link removed]) (view in English ([link removed]) )
[link removed]
CDC encourages providers to begin using these VISs immediately; however, existing supplies of the previous editions may be used until they are depleted.
IAC will post translations of current VISs into additional languages in the coming weeks at ;Immunize.org/vis ([link removed]) . Translations of previous VIS versions may be used until new translations become available. CDC states that the corresponding current English-language VIS must also be supplied when providing an out-of-date translation.
Related Links
* IAC: Vaccine Information Statements ([link removed]) gateway page for VISs in 47 languages ([link removed])
* IAC: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
IAC SPOTLIGHT: CHECK OUT IAC’S COMPANION WEBSITES
In this week's IAC Spotlight, we summarize Immunize.org companion websites.
Information about the National Network of Immunization Coalitions, a project of IAC, can be found at www.immunizationcoalitions.org ([link removed]) . This website compiles information on more than 100 immunization coalitions throughout the United States. It’s a place for coalitions to find out about each other—their location, leaders, and work—as well as to learn about topics of shared interest.
The National Adult and Influenza Immunization Summit (NAIIS) website at www.izsummitpartners.org is dedicated to addressing adult and influenza immunization issues and improving coverage. The NAIIS has over 700 members, representing more than 130 public and private organizations. Leadership of the NAIIS is provided through the members of the Summit Organizing Committee (SOC), including IAC, CDC, and HHS representatives.
Vaccine Information You Need at www.vaccineinformation.org ([link removed]) was launched by IAC in partnership with CDC to help inform the public. This website provides hundreds of valuable resources, including personal testimonies of suffering and loss due to vaccine-preventable diseases, vaccine-related videos and public service announcements, and educational materials from trusted organizations.
MenACWY: You’re Not Done If You Give Just One at www.give2menacwy.org supports a national campaign to improve protection from disease caused by meningococcal serogroups A, C, W, and Y. It offers information for families and resources for providers to boost on-time delivery of both doses of the MenACWY vaccine series.
65+ Flu Defense at www.influenza-defense.orgis a public health service produced by IAC and Seqirus. The website offers tools and resources to help protect patients 65 and older, all of whom are at greater risk of influenza complications.
Related Link
* IAC: IAC Immunization Partners ([link removed]) gateway page
------------------------------------------------------------
Journalists interview IAC experts
Journalists seek out IAC experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is a selection of our recent citations.
* Scientific American: An mRNA Pioneer Discusses How Her Work Led to the COVID Vaccines ([link removed]) (9/15/21)
* Washington Post:The U.S. Was a Global Leader in Vaccinations. Now It’s Falling Behind. ([link removed]) (9/15/21)
* Washington Times: 'Twindemic' Possible as Flu Season Approaches, Health Experts Warn ([link removed]) (9/14/21)
Related Link
* IAC in the News ([link removed]) gateway page
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* STAT News: FDA Advisory Panel Recommends Booster Doses of COVID-19 Vaccine Only for Older and High-Risk Americans ([link removed]) (9/17/21)
* The Conversation: What’s the Law on Vaccine Exemptions? A Religious Liberty Expert Explains ([link removed]) (9/15/21)
* Business Mirror: Life-Course Immunization Is Key to Promoting Healthy Ageing ([link removed]) (9/15/21)
* Washington Post: Fauci Says He Supports Vaccine Mandates for Air Travel. Will It Actually Fly? ([link removed]) (9/13/21)
* NBC: 'Hybrid Immunity': ([link removed]) Why People Who Had COVID Should Still Get Vaccinated ([link removed]) (9/13/21)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
IAC POSTS NEW TRANSLATIONS OF CURRENT VISS IN CHINESE, DARI, PASHTO, SPANISH, TURKISH, AND VIETNAMESE
IAC has posted new and updated translations of Vaccine Information Statements ([link removed]) (VISs) that were released by CDC on August 6, 2021, in Chinese, Dari, Pashto, Spanish, Turkish, and Vietnamese. All translations are available in PDF and print-ready format.
VIS translations in Simplified Chinese and Traditional Chinese ([link removed]) :
* DTaP (Diphtheria, Tetanus, Pertussis) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* HPV (Human Papillomavirus) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Influenza, inactivated or recombinant in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Influenza, live intranasal in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Meningococcal ACWY in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Meningococcal B in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* MMRV (Measles, Mumps, Rubella, and Varicella) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Pneumococcal Conjugate (PCV13) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Polio in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Td (Tetanus, Diphtheria) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Tdap (Tetanus, Diphtheria, Pertussis) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
* Varicella (Chickenpox) in Simplified ([link removed]) and Traditional ([link removed]) PDF (view in English ([link removed]) )
Simplified Chinese is preferred in China, Singapore, and Malaysia. Traditional Chinese is preferred in Hong Kong, Macau, and Taiwan.
VIS translations in Dari ([link removed]) :
* MMR (Measles, Mumps, and Rubella) PDF ([link removed]) (view in English ([link removed]) )
* Polio PDF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) PDF ([link removed]) (view in English ([link removed]) )
Dari is spoken by some people in Afghanistan and Pakistan. These VIS translations were provided to IAC by the Multilingual Services of CDC.
VIS translations in Pashto ([link removed]) :
* Hepatitis A PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated PDF ([link removed]) (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) PDF ([link removed]) (view in English ([link removed]) )
* Polio PDF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) PDF ([link removed]) (view in English ([link removed]) )
Pashto is spoken by some people in Afghanistan, Iran, and Pakistan. These VIS translations were provided to IAC by the Multilingual Services of CDC. All files are dated 8/6/2021 except for Hepatitis A which is dated 7/28/2020.
VIS translation in Spanish ([link removed]) :
The translations are available in PDF and Rich Text Format (RTF). RTF is used by electronic health record systems that cannot accept PDFs.
* DTaP (Diphtheria, Tetanus, Pertussis) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* HPV (Human Papillomavirus) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated or recombinant in PDF ([link removed]) and RTF ([link removed]) formats (view in English ([link removed]) )
* Influenza, live intranasal in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Meningococcal B in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* MMRV (Measles, Mumps, Rubella, and Varicella) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Pneumococcal Conjugate (PCV13) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Polio in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Td (Tetanus, Diphtheria) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Tdap (Tetanus, Diphtheria, Pertussis) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) in PDF ([link removed]) and RTF ([link removed]) (view in English ([link removed]) )
VIS translation in Turkish ([link removed]) :
* Influenza, live intranasal PDF ([link removed]) (view in English ([link removed]) )
This translation is generously donated by Betül Polatdemir, MD, from Ankara, Turkey, and Sibel Bostancıoğlu, MD, from the Occupational and Environmental Diseases Hospital of Ankara.
VIS translations in Vietnamese ([link removed]) :
* DTaP (Diphtheria, Tetanus, Pertussis) PDF ([link removed]) (view in English ([link removed]) )
* Haemophilus influenzae type b (Hib) PDF ([link removed]) (view in English ([link removed]) )
* HPV (Human Papillomavirus) PDF ([link removed]) (view in English ([link removed]) )
* Influenza, inactivated PDF ([link removed]) (view in English ([link removed]) )
* Influenza, live intranasal PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal ACWY PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B PDF ([link removed]) (view in English ([link removed]) )
* MMR (Measles, Mumps, and Rubella) PDF ([link removed]) (view in English ([link removed]) )
* MMRV (Measles, Mumps, Rubella, and Varicella) PDF ([link removed]) (view in English ([link removed]) )
* Pneumococcal Conjugate (PCV13) PDF ([link removed]) (view in English ([link removed]) )
* Polio PDF ([link removed]) (view in English ([link removed]) )
* Td (Tetanus, Diphtheria) PDF ([link removed]) (view in English ([link removed]) )
* Tdap (Tetanus, Diphtheria, Pertussis) PDF ([link removed]) (view in English ([link removed]) )
* Varicella (Chickenpox) PDF ([link removed]) (view in English ([link removed]) )
IAC will post translations of current VISs into additional languages in coming weeks at Immunize.org/vis ([link removed]) .
Translations of previous VIS versions may be used until translations of current VISs become available. CDC states that the corresponding current English-language VIS must also be supplied when providing a translation of a previous version.
Related Links
* IAC: Vaccine Information Statements ([link removed]) gateway page for VISs in 47 languages ([link removed])
* IAC: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Spread the word, not the virus! IAC offers FREE “I Got My COVID-19 Vaccine” buttons and stickers to those promoting vaccination in hesitant communities. Available in English and Spanish.
Any group or person promoting COVID-19 vaccination can order IAC’s FREE “I Got My COVID-19 Vaccine” buttons and stickers ([link removed]) , provided with support from CDC. Available in English and Spanish, the buttons and stickers look great on lab coats, uniforms, jackets, lanyards, ID badges, or backpacks to show confidence in COVID-19 vaccination. Access this order form ([link removed]) to request the FREE buttons and stickers for your outreach efforts while supplies last.
[link removed] [link removed]
Related Links
* IAC: FREE "I Got My COVID-19 Vaccine" buttons and stickers order form ([link removed])
* Shop IAC ([link removed]) gateway page: All the buttons, stickers, laminated schedules, record cards, and other products offered by IAC
------------------------------------------------------------
IAC'S RED "FLU VACCINE" BUTTONS AND STICKERS ARE A BRIGHT IDEA. ORDER TODAY!
Remember to order your IAC “FLU VACCINE” buttons and stickers ([link removed]) They are ready to ship! Their bright red color highlights your important message about the need for influenza vaccination. And the cost is reasonable.
[link removed]
“FLU VACCINE” BUTTONS
The button measures 1.25" across and carries a bold message! Pin on lab coats, uniforms, other clothing, tote bags, or backpacks to show support for flu vaccine.
Buttons are delivered in bags of 10 buttons per bag.
Click here for pricing and ordering information for "FLU VACCINE" buttons ([link removed]) .
“FLU VACCINE” STICKERS
Measuring 1.5" across, these stickers adhere well to clothing and have an easy-peel-off backing.
Stickers are delivered to you cut individually (not on rolls)—available in bundles of 100.
Click here for pricing and ordering information for “FLU VACCINE” stickers. ([link removed])
Visit Shop IAC for additional items ([link removed]) , including "Vaccines Save Lives" enamel pins, patient record cards, and a vaccine administration training video.
------------------------------------------------------------
Vaccinated against COVID-19? Encourage friends to follow your lead by adding IAC’s “I Got My COVID-19 Vaccine” Facebook profile photo frame.
Share your excitement about COVID-19 vaccination and inspire your friends! After you are vaccinated against COVID-19, add IAC's new "I Got My COVID-19 Vaccine" Facebook photo frame to liven up your profile picture!
You can obtain the frame in three ways:
* Click your profile picture, select “update picture,” and then select “add a frame.” Search for #igotmycovid19vaccine and select it.
* Accept the frame in English by clicking this link: www.facebook.com/profilepicframes/? selected_overlay_id=2361854253958052 ([link removed])
* Accept the frame in Spanish by clicking this link: www.facebook.com/profilepicframes/?selected_overlay_id=517990259207530
------------------------------------------------------------
GREAT GIFT IDEA! IAC'S ELEGANTLY DESIGNED "VACCINES SAVE LIVES" BLACK ENAMEL PINS MAKE WONDERFUL HOLIDAY GIFTS OR WORKPLACE RECOGNITIONS.
IAC’s elegantly designed “Vaccines Save Lives” pins ([link removed]) are meaningful gifts for people who care about vaccination. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75".
[link removed]
The pin is a stick-through-post variety with the back end covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided.
Wear these pins on clothing, ([link removed]) uniforms, and white coats to show that you value vaccines!
([link removed])
Click here for "Vaccines Save Lives" pin pricing and ordering information. ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“New COVID-19 Cases and Hospitalizations among Adults, by Vaccination Status—New York, May 3–July 25, 2021” published in MMWR
CDC published New COVID-19 Cases and Hospitalizations among Adults, by Vaccination Status—New York, May 3–July 25, 2021 ([link removed]) in the September 17 MMWR. A portion of the summary appears below.
Real-world studies of population-level vaccine effectiveness against laboratory-confirmed SARS-CoV-2 infection and COVID-19 hospitalizations are limited in the United States....
During May 3–July 25, 2021, the overall age-adjusted vaccine effectiveness against hospitalization in New York was relatively stable 89.5%–95.1%. The overall age-adjusted vaccine effectiveness against infection for all New York adults declined from 91.8% to 75.0%....
These findings support the implementation of multicomponent approach to controlling the pandemic, centered on vaccination, as well as other prevention strategies such as masking and physical distancing.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .
Related Link
* MMWR's gateway page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
“Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months” published in NEJM
In the September 15 issue, NEJM published Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months ([link removed]) . A portion of the abstract appears below.
[Pfizer-BioNTech’s] BNT162b2 is highly efficacious against coronavirus disease 2019 (Covid-19) and is currently approved, conditionally approved, or authorized for emergency use worldwide. At the time of initial authorization, data beyond 2 months after vaccination were unavailable....
In an ongoing, placebo-controlled, observer-blinded, multinational, pivotal efficacy trial, we randomly assigned 44,165 participants 16 years of age or older and 2264 participants 12 to 15 years of age to receive two 30-μg doses, at 21 days apart, of BNT162b2 or placebo. The trial end points were vaccine efficacy against laboratory-confirmed Covid-19 and safety, which were both evaluated through 6 months after vaccination....
BNT162b2 continued to be safe and have an acceptable adverse-event profile. Few participants had adverse events leading to withdrawal from the trial. Vaccine efficacy against Covid-19 was 91.3%…through 6 months of follow-up among the participants without evidence of previous SARS-CoV-2 infection who could be evaluated. There was a gradual decline in vaccine efficacy. Vaccine efficacy of 86 to 100% was seen across countries and in populations with diverse ages, sexes, race or ethnic groups, and risk factors for Covid-19 among participants without evidence of previous infection with SARS-CoV-2. Vaccine efficacy against severe disease was 96.7%…In South Africa, where the SARS-CoV-2 variant of concern B.1.351 (or beta) was predominant, a vaccine efficacy of 100%…was observed....
Through 6 months of follow-up and despite a gradual decline in vaccine efficacy, BNT162b2 had a favorable safety profile and was highly efficacious in preventing Covid-19.
------------------------------------------------------------
MMWR Recap: COVID-19 vaccine effectiveness studies
CDC recently published several articles first distributed as MMWR Early Releases:
* Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status––13 U.S. Jurisdictions, April 4–July 17, 2021 (MMWR, September 17, HTML ([link removed]) or PDF ([link removed]) )
* Interim Estimates of COVID-19 Vaccine Effectiveness against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations among Adults during SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance––Nine States, June–August 2021 (MMWR, September 17, HTML ([link removed]) or PDF ([link removed]) )
* Effectiveness of COVID-19 mRNA Vaccines against COVID-19–Associated Hospitalization—Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021 (MMWR, September 17, HTML ([link removed](Delta)%20variant.) or PDF ([link removed]) )
Related Link
* MMWR ([link removed]) gateway page provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
Global News
------------------------------------------------------------
SEPTEMBER 28 IS WORLD RABIES DAY
September 28 is World Rabies Day ([link removed]) , a global health observance started in 2007 to raise awareness about rabies and bring together partners to enhance prevention and control efforts worldwide. While rabies ([link removed]) is a 100% preventable disease, more than 59,000 people die from the disease around the world each year. World Rabies Day is an opportunity to reflect on our efforts to control this deadly disease and remind ourselves that the fight is not yet over.
September 28 was chosen because it is the anniversary of the death of Louis Pasteur, the French chemist and microbiologist who developed the first rabies vaccine. Today, safe and effective animal and human vaccines are important tools to eliminate human deaths from rabies but awareness is the key driver for effective rabies prevention.
[link removed]
Access the World Rabies Day ([link removed]) website for more information.
Related Links
* CDC: World Rabies Day ([link removed]) web page
* CDC: Rabies ([link removed]) web page
* WHO: September 28 is World Rabies Day ([link removed]) web page
* IAC: ACIP Recommendations: Rabies ([link removed]) web page
* IAC: Vaccines: Rabies ([link removed]) gateway page
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
VIRTUAL: WATCH THE ACIP MEETING ON TICK-BORNE ENCEPHALITIS, ZOSTER, AND PNEUMOCOCCAL VACCINATION ON SEPTEMBER 29; NO REGISTRATION REQUIRED
CDC will convene its Advisory Committee on Immunization Practices (ACIP) ([link removed]) on September 29, starting at 10:00 a.m. (ET). The committee will discuss tick-borne encephalitis, zoster, and pneumococcal vaccination.
No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described at the website.
View the agenda ([link removed]) .
Related Link
* ACIP gateway page ([link removed]) for content from previous meetings, as well as information about future meetings
------------------------------------------------------------
VIRTUAL: VIEW THE PANEL DISCUSSIONS “PARTNERS IN VACCINATION: A COLLABORATION BETWEEN THE AAP, AIM, AND NACCHO” ON SEPTEMBER 29 AND OCTOBER 13
The American Academy of Pediatrics (AAP), the Association of Immunization Managers (AIM), and the National Association of County and City Health Officials (NACCHO) will host "Partners in Vaccination: A Collaboration Between the AAP, AIM, and NACCHO" panel discussions from 11:30 a.m.–1:00 p.m. (CT) on both September 29 ([link removed]) and October 13
([link removed]) . These discussions will lead to a shared understanding of the role each plays in routine childhood immunization and pathways to collaboration at the local and/or state levels.
A panelist from each organization will provide a brief overview of their organization, describe the current environment for providing routine childhood immunizations, and share an illustrative example of a successful collaboration among them. Participants will come away with ideas on how to leverage their organization’s role and strengths.
Register for the September 29 session. ([link removed])
Register for the October 13 session. ([link removed])
------------------------------------------------------------
VIRTUAL: UNITY CONSORTIUM OFFERS WEBINAR “WORKING TOGETHER TO PROTECT OUR ADOLESCENTS IN SCHOOL ENVIRONMENTS FROM VACCINE-PREVENTABLE DISEASES” MODERATED BY CHELSEA CLINTON ON SEPTEMBER 30
Unity Consortium will offer Working Together to Protect Our Adolescents in School Environments from Vaccine-Preventable Diseases ([link removed]) panel discussion moderated by Chelsea Clinton on September 30 from 12:00–1:00 p.m. (ET).
The panel includes distinguished leaders from
* American Association of School Administrators (AASA)
* National School Boards Association (NSBA)
* National Association of County, and City Health Officials (NACCHO)
They will discuss promising practices that schools have adopted to help keep students and school employees safe and healthy.
Register for the event ([link removed]) .
If you can't attend, register so you will be sent the recording.
------------------------------------------------------------
Virtual: Nevada Immunization Learning Exchange offers webinar titled “COVID-19 Vaccine and Delta Variant: Facts vs. Misinformation” on September 30
Nevada Immunization Learning Exchange (NILE) will offer a webinar titled COVID-19 Vaccine and Delta Variant: Facts vs. Misinformation ([link removed]) on September 30 at 11:30 a.m. (PT). During this program, Dr. Katrine Wallace, PhD, MS, will describe recently published research on COVID-19 vaccines’ effectiveness against the Delta variant and some common vaccine misinformation on social media. The learning objectives include:
* Learn current COVID-19 vaccine effectiveness estimates against the Delta variant
* Learn methodological issues associated with determining vaccine effectiveness against infection
* Discern facts from misleading information being circulated on social media and elsewhere
Register for the webinar ([link removed]) .
[link removed]
IAC Express
IAC Express Home ([link removed])
2021 Issues ([link removed])
2020 Issues ([link removed])
2019 Issues ([link removed])
2018 ([link removed]) – (#IACX4) 1997 Issues ([link removed])
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
------------------------------------------------------------
[link removed]
[link removed]
------------------------------------------------------------
Follow Us
[link removed]
[link removed]
------------------------------------------------------------
[link removed]
Read Dr. Wexler's column for the Vaccine Education Center's monthly newsletter, Vaccine Update
------------------------------------------------------------
Vaccinating Adults:
A Step-by-Step Guide
[link removed]
New! IAC's 142-page book available for free download ([link removed]) .
------------------------------------------------------------
Calendar of Events
[link removed]
Conferences, meetings, and training opportunities
------------------------------------------------------------
Patient Record Cards
[link removed]
Record cards for patients --child & teen ([link removed]) , adult ([link removed]) , and lifetime ([link removed]) -- are printed on durable paper and sized to fit in a wallet when folded
------------------------------------------------------------
DVD: Immunization Techniques
[link removed]
Every practice should have this award winning, "how-to" training video
------------------------------------------------------------
Protect Newborns Guidebook
[link removed]
Comprehensive guide Hepatitis B: What Hospitals Need to Do to Protect Newborns ([link removed])
------------------------------------------------------------
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH (mailto:[email protected])
Managing Editor
John Grabenstein, RPh, PhD (mailto:[email protected])
Associate Editor
Sharon Humiston, MD, MPH (mailto:[email protected])
Writer/Publication Coordinator
Taryn Chapman, MS (mailto:[email protected])
Courtnay Londo, MA (mailto:[email protected])
Style and Copy Editor
Marian Deegan, JD (mailto:[email protected])
Web Edition Manager
Sheila M. Franey, MA
Contributing Writer
Laurel H. Wood, MPA (mailto:[email protected])
Technical Reviewer
Robin VanOss (mailto:[email protected])
About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue ([link removed]) .
IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC.
IAC Express Disclaimer ([link removed])
ISSN: 1526-1786
Our mailing address:
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp